Open access social media guide for pharma: Q&A

You may have heard about my open access social media guide for pharma project which we hope you will join soon! I discussed the project with Mark Senak at Eye on FDA and he advised me to create a Q&A so then people can clearly see how they can join.

  • Why do we need a social media guideline for pharma? Why open access?

FDA doesn’t seem to be ready to give us clear instructions about how pharma can or shouldn’t use social media. So we, pharma bloggers and social media faces behind major pharma companies, should create a draft that the FDA and other companies could use for free. It must be open access so then each company can take it and make it customized based on their own preferences.

  • Who can participate in this?

Anyone who is interested. To be able to edit the document, please send me an e-mail.

  • What happens in this round (until the end of July)?

Now, we need negative and positive examples of pharma using social media platforms (Twitter, Facebook, Youtube, blogs, Wikipedia, etc).

  • How can I help?

Let me know if you would like to participate and then please add your favourite case studies, cases, examples, stories about pharma using different social media platforms in a positive or negative way.

  • Who can use the guide when it is ready or what will happen with that?

Anyone can use that for free.

  • Do I get credit for my contribution?

Yes, all editors will be listed as ocntributors when we finished the draft.